Conditions and Disclosures Sample Clauses

The "Conditions and Disclosures" clause sets out specific requirements or circumstances that must be met or revealed for the agreement to be valid or for certain obligations to take effect. Typically, this clause outlines information that one or both parties must provide, such as financial statements, legal compliance documents, or other relevant disclosures, before proceeding with the contract. Its core function is to ensure transparency and protect both parties by making sure all necessary information is shared and certain prerequisites are satisfied before contractual duties are enforced.
Conditions and Disclosures. 1) I UNDERSTAND THAT ALL FEES ARE NONREFUNDABLE. I understand that my child’s space in the program is not secured following acceptance until all enrollment forms have been submitted and all fees have been paid. 2) I hereby grant to BWK the non-exclusive use of any photograph or video taken of my child, and of any artwork created by my child while at BWK. 3) I am aware that BWK does not follow the Boulder Valley Public School District calendar. The BWK calendar includes the following school closures:  1 week Thanksgiving break: Parent/Teacher Conferences and Thanksgiving holiday  1 week February Break: Waldorf Teachers Regional Conference Week  2 week December Winter Break  2 week Spring Break 4) I understand that my invoice will be emailed to me approximately a week prior to the 1st day of each month and that payment is due on the 1st of the month and MUST BE RECEIVED BY BWK NO LATER THAN THE 10TH OF THE MONTH. I understand that the above are my payment obligations and that I receive invoices as a courtesy. If BWK has not received my payment by the 10th of the month, then I agree to pay a late fee of 10% of my total balance due, or $25, whichever is greater. If late tuition is not paid by the end of the month, I may be notified by BWK that my child cannot attend BWK until my balance is paid in full. When my account is 30 days late or more, my outstanding balance shall accrue interest at the rate of 2% per month until paid in full. I agree to pay all costs of collection for amounts due under this contract including but not limited to attorney's fees and court costs. 5) I agree to pay a $25 service charge if my check or ACH is returned by the bank for insufficient funds. 6) I understand that my full payment is due each month even in cases of absence due to illness or travel, and that my child may not switch days, even in the event of absence due to illness or travel. 7) EARLY WITHDRAWAL AND SCHEDULE CHANGES: I understand that 90 days written notice is required if I choose to withdraw my child from this program before the end of the school year. I understand that I am responsible for paying tuition at my regular tuition level, as specified in this contract, for 3 monthly payments following the date of my written notice for withdrawal, for any such withdrawal notice dated after April 30, 2020 (note that this includes notices dated before the beginning of the school year). In this case, I will be invoiced by BWK for three monthly payments on the 1st of the ...
View SourceView Similar (4)
Conditions and Disclosures 
View Source

Related to Conditions and Disclosures

  • Use and Disclosure All Confidential Information of a party will be held in confidence by the other party with at least the same degree of care as such party protects its own confidential or proprietary information of like kind and import, but not less than a reasonable degree of care. Neither party will disclose in any manner Confidential Information of the other party in any form to any person or entity without the other party’s prior consent. However, each party may disclose relevant aspects of the other party’s Confidential Information to its officers, affiliates, agents, subcontractors and employees to the extent reasonably necessary to perform its duties and obligations under this Agreement and such disclosure is not prohibited by applicable law. Without limiting the foregoing, each party will implement physical and other security measures and controls designed to protect (a) the security and confidentiality of Confidential Information; (b) against any threats or hazards to the security and integrity of Confidential Information; and (c) against any unauthorized access to or use of Confidential Information. To the extent that a party delegates any duties and responsibilities under this Agreement to an agent or other subcontractor, the party ensures that such agent and subcontractor are contractually bound to confidentiality terms consistent with the terms of this Section 11.

  • Publicity and Disclosures No press releases or public disclosure, either written or oral, of the transactions contemplated by this Agreement, shall be made by a party to this Agreement without the prior knowledge and written consent of Buyer and the Company.

  • Restrictions on Use and Disclosure Covered Entity shall notify Business Associate of any restriction on the use or disclosure of PHI that Covered Entity has agreed to in accordance with 45 C.F.R. § 164.522, to the extent such restriction may affect Business Associate’s use or disclosure of PHI.

  • Permitted Use and Disclosures Each Party hereto may use or disclose Confidential Information disclosed to it by the other Party to the extent such information is included in the Pharmacopeia Technology, Schering Technology or Collaboration Technology, as the case may be, and to the extent (i) such use or disclosure is reasonably necessary and permitted in the exercise of the rights granted hereunder in filing or prosecuting patent applications, prosecuting or defending litigation, (ii) such disclosure is reasonably required to be made to any institutional review board of any entity conducting clinical trials with Agreement Compound(s) and/or Agreement Product(s), or to any governmental or other regulatory agency, in order to gain approval to conduct clinical trials or to market Agreement Compound(s) and/or Agreement Products, (iii) such disclosure is required by law, regulation, rule, act or order of any governmental authority, court, or agency, or is made in connection with submitting required information to tax or other governmental authorities, or (iv) such disclosure or use is reasonably required in conducting clinical trials, or making a permitted sublicense or otherwise exercising license rights expressly granted to it by the other Party pursuant to the terms of this Agreement; in each case, provided that if a Party is required to make any such disclosure of another Party’s Confidential Information, other than pursuant to a confidentiality agreement, it will give reasonable advance notice to the other Party of such disclosure and, save to the extent inappropriate in the case of patent applications, will use its reasonable diligent efforts to secure confidential treatment of such Confidential Information in consultation with the other Party prior to its disclosure (whether through protective orders or otherwise) and disclose only the minimum necessary to comply with such requirements.

  • Permitted Uses and Disclosures i. Business Associate shall use and disclose PHI only to accomplish Business Associate’s obligations under the Contract. i. To the extent Business Associate carries out one or more of Covered Entity’s obligations under Subpart E of 45 C.F.R. Part 164, Business Associate shall comply with any and all requirements of Subpart E that apply to Covered Entity in the performance of such obligation. ii. Business Associate may disclose PHI to carry out the legal responsibilities of Business Associate, provided, that the disclosure is Required by Law or Business Associate obtains reasonable assurances from the person to whom the information is disclosed that: A. the information will remain confidential and will be used or disclosed only as Required by Law or for the purpose for which Business Associate originally disclosed the information to that person, and; B. the person notifies Business Associate of any Breach involving PHI of which it is aware. iii. Business Associate may provide Data Aggregation services relating to the Health Care Operations of Covered Entity. Business Associate may de-identify any or all PHI created or received by Business Associate under this Agreement, provided the de-identification conforms to the requirements of the HIPAA Rules.